Subcutaneous Pain Medication To Provide Faster Pain Relief During A Sickle Cell Crisis
Posted Date: May 23, 2019
- Investigator: Caroline Freiermuth
- Type of Study: Observational/Survey
The goal of this study is to measure the impact on time to delivery of first parenteral pain medication for the treatment of vaso-occlusive episodes after initiating use of subcutaneous opioids in triage.
Any Adult Patient Who Presents To The Ed With Vaso-Occlusive Crisis, Stable Vital Signs And Has Been Deemed Eligible By The Hematologist At The University Of Cincinnati
Vaso Occlusive Episode, Sickle Cell, Pain Management
For More Information: